Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Chlorthalidone + losartan) by Laboratorios Silanes for Idiopathic (Essential) Hypertension: Likelihood of Approval
(Chlorthalidone + losartan) is under clinical development by Laboratorios Silanes and currently in Phase III for Idiopathic (Essential) Hypertension. According...
Data Insights
HCP-1803 by Hanmi Pharmaceuticals for Idiopathic (Essential) Hypertension: Likelihood of Approval
HCP-1803 is under clinical development by Hanmi Pharmaceuticals and currently in Phase III for Idiopathic (Essential) Hypertension. According to GlobalData,...